Postmenopausal women who lose weight may have reduced breast cancer risk

December 8, 2017, American Association for Cancer Research

Postmenopausal women who lose weight may have a significantly reduced chance of developing breast cancer, according to data presented at the 2017 San Antonio Breast Cancer Symposium, held Dec. 5–9.

"Breast cancer is among the leading types of cancer and causes of death in American women," said Rowan Chlebowski, MD, PhD, research professor in the Department of Medical Oncology and Therapeutics Research at City of Hope in Duarte, California. "Obesity rates have been increasing in the United States. We wanted to determine if there was a link between obesity and risk."

Several studies have associated high body mass index (BMI) with increased cancer risk, noted Chlebowski. While this risk factor is largely preventable, it is estimated that more than 65 percent of American women are overweight or obese.

"We wanted to determine if weight loss was associated with lower breast cancer incidence, as studies have not been able to consistently show that losing weight reduces the risk of breast cancer," said Chlebowski. Past studies have been limited to analyses with self-reported measurements, while the prospective study conducted by Chlebowski and colleagues utilizes a short-term, three-year period of measured body weight and height followed by a long period of follow-up.

Chlebowski and colleagues analyzed data from the Women's Health Initiative (WHI) Observational Study. This program tracks the health of postmenopausal women between the ages of 50 and 79. Participants who had a normal mammogram, no prior breast cancer, and were not underweight (BMI ≥ 18.5) were eligible for enrollment in Chlebowski's study. Measurements for height and weight were obtained upon enrollment, and measurements were reassessed three years following.

At baseline, 41 percent of women were normal weight, 34 percent were overweight, and 25 percent were obese.

Of the 61,335 patients enrolled in Chlebowski's study, 3,061 developed during an average of 11.4 years of follow-up. Compared to women with stable weight, those who lost weight (≥ 5 percent weight change) were 12 percent less likely to develop breast cancer following multivariable analysis. Weight loss of ≥ 15 percent was associated with a 37 percent reduction in breast cancer risk.

"In the three-year window of the study, relatively modest weight loss was associated with significant lowering of breast cancer incidence," said Chlebowski. "From this study, we have evidence that a strategy can be effective in lowering breast risk in ."

While weight gain (≥ 5 percent weight change) was not associated with increased overall , it was associated with more than 50 percent increased risk of .

Explore further: Weight-loss surgery may curb risk for certain cancers

Related Stories

Weight-loss surgery may curb risk for certain cancers

October 17, 2017
(HealthDay)—Weight-loss surgery could help some severely obese people reduce their risk for cancer by at least 33 percent, a new study suggests.

Type 2 diabetes associated with risk of aggressive breast cancer in black women

November 15, 2017
African American women with type 2 diabetes (often referred to as adult-onset diabetes) are at a greater risk for developing breast cancer.

Obesity associated with increased breast cancer risk in postmenopausal women

June 11, 2015
An analysis of extended follow-up data from the Women's Health Initiative clinical trials suggests that postmenopausal women who were overweight and obese had an increased risk of invasive breast cancer compared to women ...

Breast-feeding lowers mom's breast cancer risk: study

August 1, 2017
(HealthDay)—Breast-feeding helps protect women against breast cancer, a new report finds.

Low fat diet helps postmenopausal women avoid deadly breast cancers

April 15, 2016
Women who stayed on a low fat diet for approximately eight years reduced their risk of death from invasive breast cancers and improved their survival rates when compared with women who had not followed the dietary regimen, ...

Lowering dietary fat intake reduces death rates in some women with breast cancer

December 15, 2014
Among early-stage breast cancer patients who reduced their dietary fat intake for five years following a diagnosis, after over 15 years follow-up, death rates from all causes were significantly reduced in those who had hormone-unrelated ...

Recommended for you

Treatment shown to improve the odds against bone marrow cancer

December 15, 2018
Hope has emerged for patients with a serious type of bone marrow cancer as new research into a therapeutic drug has revealed improved outcomes and survival rates.

Immunotherapy combo not approved for advanced kidney cancer patients on the NHS

December 14, 2018
People with a certain type of advanced kidney cancer will not be able to have a combination of two immunotherapy drugs on the NHS in England.

New drug seeks receptors in sarcoma cells, attacks tumors in animal trials

December 13, 2018
A new compound that targets a receptor within sarcoma cancer cells shrank tumors and hampered their ability to spread in mice and pigs, a study from researchers at the University of Illinois reports.

Surgery unnecessary for many prostate cancer patients

December 13, 2018
Otherwise healthy men with advanced prostate cancer may benefit greatly from surgery, but many with this diagnosis have no need for it. These conclusions were reached by researchers after following a large group of Scandinavian ...

Lethal combination: Drug cocktail turns off the juice to cancer cells

December 12, 2018
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth—this was discovered by researchers from the University of Basel's Biozentrum two years ago. In a follow-up study, ...

Combining three treatment strategies may significantly improve melanoma treatment

December 12, 2018
A study by a team led by a Massachusetts General Hospital (MGH) investigator finds evidence that combining three advanced treatment strategies for malignant melanoma—molecular targeted therapy, immune checkpoint blockade ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.